CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
73.73
+1.77 (2.46%)
At close: Jun 29, 2026, 4:00 PM EDT
74.63
+0.90 (1.22%)
After-hours: Jun 29, 2026, 6:04 PM EDT
CG Oncology Market Cap
CG Oncology has a market cap or net worth of $6.5 billion as of June 29, 2026. Its market cap has increased by 221.94% in one year.
Market Cap
6.50B
Enterprise Value
5.45B
1-Year Change
221.94%
Ranking
Category
Stock Price
$73.73
Market Cap Chart
Since the IPO on January 25, 2024, CG Oncology's market cap has increased from $1.21B to $6.50B, an increase of 439.16%. That is a compound annual growth rate of 100.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 6.52B | 94.54% |
| Dec 31, 2025 | 3.35B | 53.40% |
| Dec 31, 2024 | 2.18B | 81.02% |
| Jan 25, 2024 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rhythm Pharmaceuticals | 7.53B |
| PTC Therapeutics | 7.00B |
| Scholar Rock Holding | 6.56B |
| Cogent Biosciences | 6.51B |
| Ligand Pharmaceuticals | 6.08B |
| Definium Therapeutics | 5.97B |
| Belite Bio | 5.85B |
| Xenon Pharmaceuticals | 5.77B |